Sofwave MedicalSOFWF 48 EBITDA Margin % is 10.06% as of Mar. 2026. GuruFocus rates SOFWF with a GF Score™ of 48/100 and a GF Value™ of $11.23 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Sofwave Medical ranks better than 57.72% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Sofwave Medical's EBITDA for the
three
months ended in Mar. 2026 was $2.46 Mil. Sofwave Medical's Revenue for the
three
months ended in Mar. 2026 was $24.41 Mil. Therefore, Sofwave Medical's EBITDA margin for the quarter that ended in Mar. 2026 was 10.06%.
Sofwave Medical (OTCPK:SOFWF) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Sofwave Medical EBITDA Margin % Related Terms
Sofwave Medical EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Sofwave Medical's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SOFWF vs ABT, SYK, MDT: EBITDA Margin % Comparison
For the Medical Devices subindustry, Sofwave Medical's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sofwave Medical EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sofwave Medical's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Sofwave Medical's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sofwave Medical (SOFWF) has a EBITDA Margin % of 10.06% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Sofwave Medical and its competitors. According to the industry distribution chart, Sofwave Medical ranks #345 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 42.3%.
Is Sofwave Medical's EBITDA Margin % too high?
Sofwave Medical's current EBITDA Margin % is 10.06%. The Medical Devices & Instruments industry median EBITDA Margin % is 7.39. Sofwave Medical's value of 10.06% is 36.2% above this industry median. Based on the distribution chart, Sofwave Medical ranks #345 out of 816 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Sofwave Medical has a GF Score™ of 48/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sofwave Medical's EBITDA Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Sofwave Medical ranks #345 out of 816 companies for EBITDA Margin %. This puts Sofwave Medical in the upper half of its industry. The industry median EBITDA Margin % is 7.39. Sofwave Medical's value of 10.06% is 36.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.39, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sofwave Medical's current EBITDA Margin % of 10.06% is 36.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Sofwave Medical and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sofwave Medical's current EBITDA Margin % is 10.06%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sofwave Medical stock overvalued right now?
Based on GuruFocus' analysis, Sofwave Medical (SOFWF) is currently considered Significantly Overvalued. The stock's GF Value™ is $11.23, compared to a current price of $16.00 — trading 42.5% above its estimated fair value. The current EBITDA Margin % is 10.06% and 36.2% above the Medical Devices & Instruments industry median of 7.39. Sofwave Medical's overall GF Score™ is 48/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Sofwave Medical (SOFWF), the current EBITDA Margin % is 10.06% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sofwave Medical (SOFWF) Overvalued in 2026?
Based on GuruFocus' analysis, Sofwave Medical stock appears to be overvalued.
The current stock price of $16.00 is trading 42.5% above its estimated GF Value™ of $11.23.
GuruFocus considers Sofwave Medical to be Significantly Overvalued.
Key valuation signals for SOFWF:
EBITDA Margin %: 10.06%
GF Value™: $11.23 vs. price of $16.00 (42.5% above fair value)
Industry Position: 36.2% above the Medical Devices & Instruments median (#345 of 816)
No single metric tells the full story. See the SOFWF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SOFWF has been successfully added to your 
